Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Tom Hua who wrote (786)	3/17/2000 9:05:00 AM
From: allen menglin chen	Respond to of 1298

Great, see if we can stay above 30 today. Many March 30, 35 calls will expire today worthless. Bot CEGE Oct 65 calls @ 3 1/8 when CEGE was trading around 26. Will buy more calls under 20 :) Hope you pick up some IMCL under 90 yesterday.

To: Tom Hua who wrote (786)	3/17/2000 10:06:00 PM
From: Timoteo	Read Replies (2) \| Respond to of 1298

It may be a while before fund managers buy into the biotech sector, but one never knows. I think many people are still unaware of the whole CEGE story-specifically the cash and ABGX share. It doesn't show in any of the typical profiles so if one doesn't do the DD CEGE is just another "overpriced" biotech. One of my few other tech holdings is BRKT, which is a great company that dropped about 30% this week for no reason. Many investors don't realize that they own 6 million shares of ISPD which is worth more than half BRKT's current market cap. I guess the key is just patience. Best, Timoteo